3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
4
Phase 1
2
Phase 3
1
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
8
Head & Neck
1
Conditions
Head and Neck Neoplasms
174
Squamous Cell Carcinoma of Head and Neck
147
Nasopharyngeal Carcinoma
126
Oropharyngeal Neoplasms
25
Thyroid Neoplasms
23
Nasopharyngeal Neoplasms
21
Mouth Neoplasms
21
Carcinoma, Squamous Cell
19
Laryngeal Neoplasms
17
Neoplasms
15
Radiation Injuries
13
Hypopharyngeal Neoplasms
13
Salivary Gland Neoplasms
11
Carcinoma
11
Stomatitis
10
Recurrence
10
Laryngeal Diseases
10
Tongue Neoplasms
9
Mucositis
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Pain
7
Neoplasm Metastasis
7
Esthesioneuroblastoma, Olfactory
7
Xerostomia
6
Uterine Cervical Neoplasms
6
Differentiated Thyroid Cancer
6
Breast Neoplasms
6
Thyroid Cancer, Papillary
5
Parathyroid Neoplasms
4
Melanoma
4
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Respiratory Tract Diseases
×
Head & Neck
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts